Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 2.50 (10.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.40
Prev. Close: 25.00
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

KRM22 announces Market Risk solution for the GRP

20 Nov 2019 08:03

RNS Number : 0299U
KRM22 PLC
20 November 2019
 

KRM22 plc("KRM22", the "Group" or the "Company")

 

KRM22 announces Market Risk solution for the Global Risk Platform

 

KRM22 plc (AIM: KRM.L), , a global leader in delivering Enterprise, Regulatory and Market Risk Management solutions for capital markets companies, has announced the availability of its Market Risk solution on its SaaS-based Global Risk Platform.

 

The Global Risk Platform creates significant cost savings for customers and now has a unique "end to end" market risk offering that is changing the way industry participants think about evaluating market risk and satisfying regulatory requirements. KRM22's Market Risk solution allows Futures Clearing Merchants (FCM), Asset Managers, Broker Dealers and Hedge Funds to significantly enhance pre-trade, at-trade and post-trade risk management.

 

By leveraging KRM22's "Global / Local" deployment architecture, market risk managers can calculate real-time pre-trade and at trade analytics by account and portfolio showing margin sensitivities, "Greek calculations", NetLiq values and P&L performance with low latency and high performance.  Sophisticated post-trade stressing for volatility and pricing are available on equities, futures, options and FX. Firm-wide, portfolio and account-based value at risk (VaR) measurements on historic, parametric and/or modeled basis across all asset classes are now available end of day and intra-day through the Global Risk Platform.

 

While these risk tools provide analytics to help portfolio management and modify trading behavior, KRM22's Market Risk solution includes a centralized order limit management system that provides simultaneous control, approval and audit of limits in multiple independent trading applications.

 

Stephen Casner, President of KRM22, commented: "Bringing Pre-trade, At-trade and Post trade solutions onto one common SaaS based platform creates the cost and operational efficiencies our clients require in this increasingly competitive market. Having to choose a solution that is either deep enough to support complex analytics or fast enough to provide real time answers is now a thing of the past as both are now part of the Global Risk Platform.

 

"The technical upgrade to our systems is significant; all our Market Risk products can now be accessed through the single, dual-authenticated Global Risk Platform that is hosted globally by our partner at Amazon Web Services. We have also announced a program that eliminates the local installation requirements of our legacy market risk applications (ProOpticus and Risk Monitor) and have made those applications available as 'desk-top free' services."

 

 

Keith Todd, Executive Chairman and CEO of KRM22, commented: "Bringing all of our Market Risk solutions onto one common platform has been a key goal for us in 2019 that we are proud to complete. The success we demonstrate in bringing legacy applications into our next-generation Global Risk Platform is not limited to our Market Risk solutions. In less than two years, we have created a Global Risk Platform that now includes over 14 industry leading products across Regulatory, Market, Operations and Enterprise Risk." 

 

 

For further information please contact:

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne / Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

See more about KRM22 at KRM22.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGMMZMRGMGLZG
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.